<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37048697</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Long-COVID-19 in Asymptomatic, Non-Hospitalized, and Hospitalized Populations: A Cross-Sectional Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2613</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12072613</ELocationID><Abstract><AbstractText>A substantial proportion of coronavirus disease 2019 (COVID-19) survivors continue to suffer from long-COVID-19 (LC) symptoms. Our study aimed to determine the risk factors for LC by using a patient population from Northern Cyprus. Subjects who were diagnosed with severe acute respiratory syndrome-2 (SARS-CoV-2) infection in our university hospital were invited and asked to fill in an online questionnaire. Data from 296 survivors who had recovered from COVID-19 infection at least 28 days prior the study was used in the statistical analysis. For determination of risk factors for "ongoing symptomatic COVID-19 (OSC)" and "Post-COVID-19 (PSC)" syndromes, the patient population was further divided into group 1 (Gr1) and group 2 (Gr2), that included survivors who were diagnosed with COVID-19 within 4-12 weeks and at least three months prior the study, respectively. The number of people with post-vaccination SARS-CoV-2 infection was 266 (89.9%). B.1.617.2 (Delta) (41.9%) was the most common SARS-CoV-2 variant responsible for the infections, followed by BA.1 (Omicron) (34.8%), B.1.1.7 (Alpha) (15.5%), and wild-type SARS-CoV-2 (7.8%). One-hundred-and-nineteen volunteers (40.2%) stated an increased frequency of COVID-19-related symptoms and experienced the symptoms in the week prior to the study. Of those, 81 (38.8%) and 38 (43.7%) were from Gr1 and Gr2 groups, respectively. Female gender, chronic illness, and symptomatic status at PCR testing were identified as risk factors for developing OSC syndrome, while only the latter showed a similar association with PSC symptoms. Our results also suggested that ongoing and persistent COVID-19-related symptoms are not influenced by the initial viral cycle threshold (Ct) values of the SARS-CoV-2, SARS-CoV-2 variant as well as vaccination status and type prior to COVID-19. Therefore, strategies other than vaccination are needed to combat the long-term effect of COVID-19, especially after symptomatic SARS-CoV-2 infection, and their possible economic burden on healthcare settings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bostanci</LastName><ForeName>Aysegul</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4319-9032</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology and Clinical Microbiology, Faculty of Medicine, Near East University, Nicosia 99138, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gazi</LastName><ForeName>Umut</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0001-9945-478X</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology and Clinical Microbiology, Faculty of Medicine, Near East University, Nicosia 99138, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosun</LastName><ForeName>Ozgur</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-1995-9425</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, Faculty of Medicine, Near East University, Nicosia 99138, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suer</LastName><ForeName>Kaya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Near East University, Nicosia 99138, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unal Evren</LastName><ForeName>Emine</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9455-0473</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Kyrenia, Kyrenia 99320, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evren</LastName><ForeName>Hakan</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8247-8144</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Kyrenia, Kyrenia 99320, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanlidag</LastName><ForeName>Tamer</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>DESAM Research Institute, Near East University, Nicosia 99138, Cyprus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">asymptomatic</Keyword><Keyword MajorTopicYN="N">cross-sectional study</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">questionnaire</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">symptomatic</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37048697</ArticleId><ArticleId IdType="pmc">PMC10095523</ArticleId><ArticleId IdType="doi">10.3390/jcm12072613</ArticleId><ArticleId IdType="pii">jcm12072613</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Uzun O., Akpolat T., Varol A., Turan S., Bektas S.G., Cetinkaya P.D., Dursun M., Bakan N., Ketencioglu B.B., Bayrak M., et al. COVID-19: Vaccination vs. hospitalization. Infection. 2022;50:747&#x2013;752. doi: 10.1007/s15010-021-01751-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01751-1</ArticleId><ArticleId IdType="pmc">PMC8725959</ArticleId><ArticleId IdType="pubmed">34984646</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-2019) Condition or Long COVID: A Meta-Analysis and Systemic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long-covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V., Gao M., West E.A., Ballouz T., Menges D., Hanson S.W., Puhan M.A. Long COVID Through a Public Health Lens: An Umbrella Review. Public Health Rev. 2022;43:1604501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker A.M., Brigham E., Connolly B., McPeake J., Agranovich A.V., Kenes M.T., Casey K., Reynolds C., Schmidt K.F.R., Kim S.Y., et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: A multidisciplinary model of care. Lancet Respir. Med. 2021;9:1328&#x2013;1341. doi: 10.1016/S2213-2600(21)00385-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00385-4</ArticleId><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK: 1 September 2022.  [(accessed on 1 October 2022)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1september2022.</Citation></Reference><Reference><Citation>Lapa J., Rosa D., Mendes J.P.L., Deusdara R., Romero G.A.S. Prevalence and Associated Factors of Post-COVID-19 Syndrome in a Brazilian Cohort after 3 and 6 Months of Hospital Discharge. Int. J. Environ. Res. Public Health. 2023;20:848. doi: 10.3390/ijerph20010848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20010848</ArticleId><ArticleId IdType="pmc">PMC9820092</ArticleId><ArticleId IdType="pubmed">36613170</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. Lancet eClin. Med. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R., Davis A., Stanley B., Julious S., Ryan D., Jackson D.J., Halpin D.M.G., Hickman H., Quint J.K., Khunti K., et al. Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients. Pragmat. Obs. Res. 2021;12:93&#x2013;104. doi: 10.2147/POR.S316186.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/POR.S316186</ArticleId><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O&#x2019;Hara M.E., Hastie C., Roderick P., Yao G., Alwan N.A. Characteristics and impact of Long Covid: Findings from an online survey. PLoS ONE. 2022;17:e0264331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Ergoren M.C., Tuncel G., Ozverel C.S., Sanlidag T. Designing In-House SARS-CoV-2 RT-qPCR Assay for Variant of Concerns. Glob. Med. Genet. 2022;9:252&#x2013;257. doi: 10.1055/s-0042-1756660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1756660</ArticleId><ArticleId IdType="pmc">PMC9489470</ArticleId><ArticleId IdType="pubmed">36147624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamurova B., Akan G., Mogol E., Turgay A., Tuncel G., Evren E.U., Evren H., Suer K., Sanlidag T., Ergoren M.C. Strong Association between Vitamin D Receptor Gene and Severe Acute Respiratory Syndrome coronavirus 2 Infectious Variants. Glob. Med. Genet. 2023;10:27&#x2013;33. doi: 10.1055/s-0043-1761924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1761924</ArticleId><ArticleId IdType="pmc">PMC9935054</ArticleId><ArticleId IdType="pubmed">36819669</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Owen R., Thomas C., Yates J., Ferraro F.V., Skipper L., Barley-McMullen S., Brown D.A., Arena R., Ashton R.E.M. Is long COVID the next global health crisis? J. Glob. Health. 2022;12:03067. doi: 10.7189/jogh.12.03067.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.03067</ArticleId><ArticleId IdType="pmc">PMC9597397</ArticleId><ArticleId IdType="pubmed">36285549</ArticleId></ArticleIdList></Reference><Reference><Citation>Loreche A.M., Pepito V.C.F., Dayrit M.M. Long Covid: A call for global action. Public Health Chall. 2023;2:2&#x2013;4. doi: 10.1002/puh2.69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/puh2.69</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Gualano M.R., Rossi M.F., Gris A.V., Sisti L.G., Borrelli I., Santoro P.E., Tumminello A., Gentili C., Malorni W., et al. Post-Acute COVID-19 Sequelae in a Working Population at One Year Follow-Up: A wide Range of Impacts from an Italian Sample. Int. J. Environ. Res. Public Health. 2022;19:1093. doi: 10.3390/ijerph191711093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191711093</ArticleId><ArticleId IdType="pmc">PMC9518581</ArticleId><ArticleId IdType="pubmed">36078808</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Ji P., Pang J., Zhong Z., Li H., He C., Zhang J., Zhao C. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J. Med. Virol. 2020;92:1902&#x2013;1914. doi: 10.1002/jmv.25884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25884</ArticleId><ArticleId IdType="pmc">PMC7262119</ArticleId><ArticleId IdType="pubmed">32293716</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Muniz M.M., Arias A., Mata-Vazquez E., Martin-Toledano M., Lopez-Larramona G., Ruiz-Chicote A.M., Nieto-Sandoval B., Lucendo A.J. Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge. J. Clin. Med. 2021;10:2945. doi: 10.3390/jcm10132945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132945</ArticleId><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-las-Penas C., Palacios-Cena D., Gomez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Mazano G., Navarro-Santana M. Prevalence of Post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-las-Penas C., Martin-Guerrero J.D., Pellicer-Valero O., Navarro-Pardo E., Gomez-Mayordomo V., Cuadrado M.L., Arias-Navalon J., Cigaran-Mendez M., Hernandez-Barrera Arendt-Nielsen L. Female Sex Is a Risk Factor Associated with Longer-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmarinas M.C., Jubilo K.G., Samranvedhya J., Lipsitch M., Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;373:n1098. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez D.A.G., Fonseca-Aguero A., Toledo-Ibarra G.A., Gomez-Valdivia J.D.J., Diaz-Resendiz K.J.G., Benitez-Trinidad A.B., Razura-Carmona F.F., Navidad-Murrieta M.S., Covantes-Rosales C.E., Giron-Perez M.I. Post-COVID-19 Syndrome in Outpatients and Its Association with Viral Load. Int. J. Environ. Res. Public Health. 2022;19:2&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9690223</ArticleId><ArticleId IdType="pubmed">36429864</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Lie M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int J Environ Res and Public Health. 2022;19:12422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouabida K., Malas K., Talbot A., Desrosiers M.E., Lavoie F., Lebouche B., Taguemout M., Rafie E., Lessard D., Pomey M.P. Remote Patient Monitoring Program for COVID-19 Patients Following Hospital Discharge: A Cross-Sectional Study. Front. Digit. Health. 2021;3:721044. doi: 10.3389/fdgth.2021.721044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fdgth.2021.721044</ArticleId><ArticleId IdType="pmc">PMC8630581</ArticleId><ArticleId IdType="pubmed">34859244</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S., Tsuzuki S., Suzuki M., Terada M., Akashi M., Osanai Y., Kuge C., Sanada M., Tanaka K., Maruki T., et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J. Infect. Chemother. 2022;28:1546&#x2013;1551. doi: 10.1016/j.jiac.2022.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K., Kristoffersen D.T., Dell&#x2019;Isola A., Kiadaliri A., Turkiewicz A., Runhaar J., Bierma-Zeinstra S., Englund M., Magnus P.M., Kinge J.M. Post-covid medical complaints after SARS-COV-2 Omicron vs Delta variants&#x2014;A propective cohort study. Nat. Commun. 2022;13:7363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong B.V., Larpruenrudee P., Fang T., Hossain S.I., Saha S.C., Gu Y., Islam M.S. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant? Int. J. Environ. Res. Public Health. 2022;19:4586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9032753</ArticleId><ArticleId IdType="pubmed">35457468</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Azman A.S., Chen X., Zou J., Tian Y., Sun R., Xu X., Wu Y., Lu W., Ge S., et al. Global landscape of SARS-CoV-2 genomic surveillance and data sharing. Nat. Genet. 2022;54:499&#x2013;507. doi: 10.1038/s41588-022-01033-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01033-y</ArticleId><ArticleId IdType="pmc">PMC9005350</ArticleId><ArticleId IdType="pubmed">35347305</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>